PharmaCyte Biotech share price logo

PharmaCyte Biotech

NASDAQ: PMCB

$0.49

+0.01

(+2.35%)

Live

as on

PharmaCyte Biotech Stock Performance

as on September 4, 2026 at 2:08 am IST

  • Day's High

    $0.49
    $0.50

    2.04%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.48
    $1.51
    downward going graph

    2.04%

    Downside

    208.16%

    Upside

    downward going graph

PharmaCyte Biotech share price movements today

Previous Close
$0.48
Open
$0.49
Volume
30.9K
Market Cap
$5.4M
Day's Low - High
$0.49 - $0.50
52 Week Low - High
$0.48 - $1.51

PharmaCyte Biotech Historical Returns

1 Month Return
-15.26 %
3 Month Return
-35.02 %
1 Year Return
-47.6 %
3 Year Return
-80.32 %
5 Year Return
-85.77 %

PharmaCyte Biotech Stock Fundamentals & Key Indicators

Check PharmaCyte Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.4M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-44.72%

PharmaCyte Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PharmaCyte Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$5.4M-85.77%NA0.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for PharmaCyte Biotech Stock including INR - Dollar returns

The PharmaCyte Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PharmaCyte Biotech investment value today

Current value as on today

₹56,427

Returns

-₹43,573

(-43.57%)

Returns from PharmaCyte Biotech Stock

-₹47,397 (-47.4%)

Dollar Impact

₹3,824 (+3.82%)

Analyst Recommendation on PharmaCyte Biotech Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Indian Investors' Interest in PharmaCyte Biotech Stock

Search interest for PharmaCyte Biotech Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

PharmaCyte Biotech Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
-1
-1
-1
0
-1
0
-1
-2
-2
EBITDA
-1
-
-1
-1
0
-
0
-1
-2
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
1
23
-1
-3
11
-8
-7
0
-4
Income Tax Expense
0
-
1
-
-
-
-
-
-
-
Net Income
0
1
23
-1
-3
11
-8
-7
0
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PharmaCyte Biotech Annual Profit & Loss

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-4
-6
-4
-3
-3
-4
-6
-8
-4
-6
EBITDA
-4
-6
-4
-3
-3
-4
-6
-6
-4
-5
Interest Expense
0
-
-
0
0
0
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-4
-6
-4
-3
-3
-4
-4
0
30
-19
Income Tax Expense
0
0
0
0
0
0
-1
-6
-
-
Net Income
-4
-6
-4
-3
-3
-4
-4
0
30
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PharmaCyte Biotech Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Net Income
1
23
-1
-3
11
-8
-7
0
-4
Operating Cash Flow
0
0
-1
0
-1
-1
0
0
-1
Investing Cash Flow
-
-7
7
-
-
-
-3
5
1,999,998
Financing Cash Flow
-10
-10
-10
-3
0
0
6
0
0
Change in Cash
-11
-17
-11
-4
-1
-1
2
4
-1

PharmaCyte Biotech Annual Cash Flow

All numbers in Millions USD

Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Net Income
-6
-4
-3
-3
-4
-4
0
30
-19
Operating Cash Flow
-5
-2
-2
-3
-4
-3
-2
-2
-5
Investing Cash Flow
-
-
-
-
-
-
-5
-7
2
Financing Cash Flow
2
2
2
4
87
-13
-10
-25
6
Change in Cash
-2
0
0
1
83
-17
-17
-35
3

Mutual Funds that own PharmaCyte Biotech Stock

Check out the Mutual Funds with significant holdings in PharmaCyte Biotech.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
1.018559%
109349
VANGUARD INDEX FUNDS
0.479402%
51467
Victory Portfolios III
0.016803%
1804

Global Institutional Holdings in PharmaCyte Biotech

Funds
Holdings
Vanguard
0.53%

Insights on PharmaCyte Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 577.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 114.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PMCB stock has moved down by -11.0%

About PharmaCyte Biotech

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
OrganisationPharmaCyte Biotech
Headquarters3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169
IndustryBiotechnology
CEOMr. Joshua N. Silverman
E-voting on sharesClick here to vote

Key Management of PharmaCyte Biotech

Name

Title

Mr. Joshua N. Silverman

CEO. President & Executive Chairman

Mr. Carlos A. Trujillo CPA

Chief Financial Officer

Dr. Jose L. Iglesias M.D.

Consulting Chief Medical Officer

Dr. Hans-Peter Hammes M.D.

Member of Medical & Scientific Advisory Board and Consultant

FAQs

What is PharmaCyte Biotech share price today?

PharmaCyte Biotech share price today is $0.49 as on . PharmaCyte Biotech share today touched a day high of $0.50 and a low of $0.49.

What is the 52 week high and 52 week low for PharmaCyte Biotech share?

PharmaCyte Biotech share touched a 52 week high of $1.51 on and a 52 week low of $0.48 on . PharmaCyte Biotech stock price today i.e. is trending at $0.49,which is 67.55% down from its 52 week high and 2.08% up from its 52 week low.

What is PharmaCyte Biotech's market capitalisation today?

PharmaCyte Biotech market capitalisation is $0.00T as on .

How to invest in PharmaCyte Biotech Stock (PMCB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PharmaCyte Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PharmaCyte Biotech Shares that will get you 3.0612 shares as per PharmaCyte Biotech share price of $0.49 per share as on September 3, 2026 at 8:38 pm IST.

What is the minimum amount required to buy PharmaCyte Biotech Stock (PMCB) from India?

Indian investors can start investing in PharmaCyte Biotech (PMCB) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in PharmaCyte Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on PharmaCyte Biotech share’s latest price of $0.49 as on September 3, 2026 at 8:38 pm IST, you will get 20.4082 shares of PharmaCyte Biotech. Learn more about fractional shares .

What are the returns that PharmaCyte Biotech has given to Indian investors in the last 5 years?

PharmaCyte Biotech stock has given -85.77% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?